Proteomic patterns of tumour subsets in non-small-cell lung cancer

Lancet

Volumn 362, Issue 9382, 2003, Pages 433-439

  Yanagisawa, Kiyoshi ^a,b   Shyr, Yu ^b   Xu, Baogang J ^b   Massion, Pierre P ^a,b   Larsen, Paul H ^b   White, Bill C ^a,b   Roberts, John R ^a,b   Edgerton, Mary ^b   Gonzalez, Adriana ^b   Nadaf, Sorena ^a,b   Moore, Jason H ^a,b   Caprioli, Richard M ^b   Carbone, David P ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FROZEN SECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL ASSESSMENT; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; SAMPLE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 0041735992     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14068-8     Document Type: Article

References (33)

1. Carbone D.P. The biology of lung cancer. Semin Oncol. 24:1997;388-401.
2. Minna J.D. Neoplasms of the lung. Fauci A.S., Braunwald E., Isselbacher K.J., et al. Harrison's Principles of Internal Medicine. 15th edn:2001;562-571 McGraw-Hill, New York.
3. Beer D.G., Kardia S.L., Huang C.C., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8:2002;816-824.
4. Bhattacharjee A., Richards W.G., Staunton J., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 98:2001;13790-13795.
5. Garber M.E., Troyanskaya O.G., Schluens K., et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:2001;13784-13789.
6. Wilkins M.R., Sanchez J.C., Williams K.L., Hochstrasser D.F. Current challenges and future applications for protein maps and post- translational vector maps in proteome projects. Electrophoresis. 17:1996;830-838.
7. Anderson L., Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. 18:1997;533-537.
8. Caprioli R.M., Farmer T.B., Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 69:1997;4751-4760.
9. Chaurand P., DaGue B.B., Pearsall R.S., Threadgill D.W., Caprioli R.M. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics. 1:2001;1320-1326.
10. Chaurand P., Schwartz S.A., Caprioli R.M. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol. 6:2002;676-681.
11. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 7:2001;493-496.
12. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
13. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537.
14. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest. 111:1997;1710-1717.
15. Junker K., Wiethege T., Muller K.M. Pathology of small-cell lung cancer. J Cancer Res Clin Oncol. 126:2000;361-368.
16. Xu B.J., Caprioli R.M., Sanders M.E., Jensen R.A. Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. J Am Soc Mass Spectrom. 13:2002;1292-1297.
17. Shyr Y. Tumor proteomic patterns predict classification and tumor behavior in human non-small cell lung cancer. http://vicc.org/biostatistics/lancet_lung_data.htm (accessed July 23, 2003).
18. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 98:2001;5116-5121.
19. Hedenfalk I., Duggan D., Chen Y., et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 344:2001;539-548.
20. Tukey J.W. Tightening the clinical trial. Control Clin Trials. 14:1993;266-285.
21. Shyr Y., KyungMann K. Weighted flexible compound covariate method for classifying microarray data. Berrar D. A practical approach to microarray data analysis. 2003;Kluwer Academic Publishers, Norwell.
22. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:1998;14863-14868.
23. Adam B.L., Qu Y., Davis J.W., et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:2002;3609-3614.
24. Paweletz C.P., Trock B., Pennanen M., et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 17:2001;301-307.
25. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577.
26. Petricoin E.F. 3rd, Ornstein D.K., Paweletz C.P., et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 94:2002;1576-1578.
27. Alarcon-Vargas D., Ronai Z. SUMO in cancer - wrestlers wanted. Cancer Biol Ther. 1:2002;237-242.
28. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol. 2:2001;202-210.
29. Melchior F. SUMO - nonclassical ubiquitin. Annu Rev Cell Dev Biol. 16:2000;591-626.
30. Buschmann T., Fuchs S.Y., Lee C.G., Pan Z.Q., Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell. 101:2000;753-762.
31. Hall A.K. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer. 48:1991;672-677.
32. Paciucci R., Berrozpe G., Tora M., Navarro E., Garcia de Herreros A., Real F.X. Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization. FEBS Lett. 385:1996;72-76.
33. Kobayashi T., Okada F., Fujii N., et al. Thymosin-β4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol. 160:2002;869-882.